GRAND RAPIDS — Drug developer Tetra Discovery Partners Inc. plans to launch a clinical trial later this spring on a potential treatment for an autism spectrum disorder.

Published in Health Care

GRAND RAPIDS — In the three years since Peter Jones moved from Los Angeles to Grand Rapids, he’s helped to more than double the amount of federal research funding that Van Andel Institute receives.

Published in Breaking News

If Mark Gurney can’t find the capital he needs in Michigan, his drug development firm is poised to look for it elsewhere.

Published in Health Care

At some point in the coming months, Mark Gurney and directors at Tetra Discovery Partners LLC will decide which road to travel into the future for their company.

Published in Health Care